Skip to main content
. Author manuscript; available in PMC: 2014 Jan 27.
Published in final edited form as: Am J Surg Pathol. 2013 Sep;37(9):1349–1356. doi: 10.1097/PAS.0b013e318290427d

FIGURE 3.

FIGURE 3

Kaplan-Meier survival curves for p16-positive and p16-negative patient cohorts. (p16 positive, >50% of tumor cells with nuclear and cytoplasmic staining; p16 negative, no tumor cell staining or staining in <50% of tumor cells).